+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pericarditis Drug"

Pericarditis - Pipeline Insight, 2024 - Product Thumbnail Image

Pericarditis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
Recurrent Pericarditis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Recurrent Pericarditis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Pericarditis is a condition that affects the pericardium, the thin sac that surrounds the heart. It is usually caused by a viral infection, but can also be caused by other conditions such as autoimmune diseases, radiation therapy, or trauma. Treatment for pericarditis typically involves anti-inflammatory medications, such as non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Other medications, such as colchicine, may also be used to reduce inflammation. The pericarditis drug market is a subset of the larger cardiovascular drug market. It is composed of medications used to treat pericarditis, such as NSAIDs, corticosteroids, and colchicine. These drugs are used to reduce inflammation and pain associated with the condition. Some of the companies in the pericarditis drug market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. These companies produce a variety of medications used to treat pericarditis, including NSAIDs, corticosteroids, and colchicine. Show Less Read more